Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Revenue (2025 - 2026)

Updated

Global Innovative Platforms' Revenue came in at $50,700 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 52.4% from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Revenue (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Global Innovative Platforms reported Revenue of $187,200.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 25.31 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 16.99 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.38 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 15.03 Bn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - 50,700.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50,700.00
Mar 31, 2026 106,500.00
Dec 31, 2025 30,000.00
API Access

Global Innovative Platforms Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=GIPL&period=max&api_key=YOUR_API_KEY